NIFTY23,4060.33%
SENSEX74,3460.41%
BANKNIFTY54,1860.88%
NIFTY IT29,3845.57%
PHARMA24,0870.33%
AUTO26,0930.05%
FMCG48,1241.01%
METAL13,5350.17%
REALTY762.601.39%
ENERGY40,1970.02%
NIFTY23,4060.33%
SENSEX74,3460.41%
BANKNIFTY54,1860.88%
NIFTY IT29,3845.57%
PHARMA24,0870.33%
AUTO26,0930.05%
FMCG48,1241.01%
METAL13,5350.17%
REALTY762.601.39%
ENERGY40,1970.02%

Cipla Health Ltd. Targets Significant Expansion Over Next Five Years

Cipla Health Ltd., the over-the-counter (OTC) arm of Cipla Ltd., is planning a substantial growth strategy, aiming to expand its business by 2-3 times over the next five years. This ambitious expansion plan is expected to drive the company deeper into key markets, including sexual wellness, premium skincare, and everyday health products.

The company's focus on these high-growth areas is expected to contribute significantly to its expansion objectives. By targeting these markets, Cipla Health Ltd. aims to capitalize on the growing demand for OTC products and solidify its position in the industry.

Read also: Oshea Herbals Aims for Rs 650 Crore Revenue Amidst Expansion Efforts

Investor Takeaway

Investors should consider the growth potential of Cipla Health Ltd. in the Pharma & Healthcare sector.

IPOScanner Logo

IPOScanner helps investors track upcoming, live and past IPOs in one place with GMP, subscription, allotment status and listing performance insights.

About IPO Scanner

IPOScanner is built for investors who want a clear view of every IPO opportunity in one place. From upcoming issues to live subscription data, allotment updates and listing performance, we bring together the key details you need to track the primary market.

Our tools are designed to be simple, fast and investor-friendly so you can focus on evaluating businesses instead of opening multiple tabs and websites for basic information.

Details of client bank account
For any query / feedback / clarifications, email at
[email protected].

Please read all offer documents and risk disclosures carefully before investing. IPOScanner does not provide investment advice and information on this site should not be treated as a recommendation to apply for any IPO.

© 2026 IPO Scanner. All rights reserved.